Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients
- 1 February 2019
- journal article
- letter
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 17 (3) , 568-570
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Is there a role for thioguanine therapy in IBD in 2017 and beyond?Expert Review of Gastroenterology & Hepatology, 2017
- Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapyAlimentary Pharmacology & Therapeutics, 2013
- Nodular regenerative hyperplasia: Evolving concepts on underdiagnosed cause of portal hypertensionWorld Journal of Gastroenterology, 2011
- Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasiaScandinavian Journal of Gastroenterology, 2008
- 6-Thioguanine Associated Nodular Regenerative Hyperplasia in Patients With Inflammatory Bowel Disease May Induce Portal HypertensionAmerican Journal of Gastroenterology, 2007
- Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprineGut, 2007
- Nodular regenerative hyperplasia of the liver: An under‐recognized cause of portal hypertension in hematological disordersAmerican Journal of Hematology, 2004
- Micronodular Transpormation (Nodular Regenerative Hyperplasia) of the Liver: A Report of 64 Cases Among 2,500 Autopsies and A New Classification of Benign Hepatocellular NodulesHepatology, 1990